ArticleProceedings of the National Academy of Sciences of the United States of America2003

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.

Markus Letsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.